Statement Of Financial Position [Abstract]

Biocartis Group NV - Filing #3122958

Concept	As at 2022-12-31	As at 2022-12-31	As at 2022-12-31	As at 2022-12-31	As at 2022-12-31	As at 2022-12-31	As at 2022-12-31	As at 2021-12-31	As at 2021-12-31	As at 2021-12-31	As at 2021-12-31	As at 2021-12-31	As at 2021-12-31	As at 2021-12-31	As at 2020-12-31	As at 2020-12-31	As at 2020-12-31	As at 2020-12-31	As at 2020-12-31	As at 2020-12-31	As at 2020-12-31
Statement of financial position [abstract]
Assets [abstract]
Property, plant and equipment	31,527,000 EUR	—	—	—	—	—	—	—	37,192,000 EUR	—	—	—	—	—	—	—	—	—	—	—	—
Intangible assets other than goodwill	4,770,000 EUR	—	—	—	—	—	—	—	5,067,000 EUR	—	—	—	—	—	—	—	—	—	—	—	—
Deferred tax assets	1,664,000 EUR	—	—	—	—	—	—	—	1,595,000 EUR	—	—	—	—	—	—	—	—	—	—	—	—
Cash and cash equivalents	26,125,000 EUR	—	—	—	—	—	—	—	53,522,000 EUR	—	—	—	—	—	—	—	—	—	—	—	123,668,000 EUR
Assets	114,277,000 EUR	—	—	—	—	—	—	—	142,480,000 EUR	—	—	—	—	—	—	—	—	—	—	—	—
Equity and liabilities [abstract]
Equity [abstract]
Issued capital	220,302,000 EUR	—	—	—	—	—	—	—	220,657,000 EUR	—	—	—	—	—	—	—	—	—	—	—	—
Retained earnings	443,363,000 EUR	—	—	—	—	—	—	—	526,405,000 EUR	—	—	—	—	—	—	—	—	—	—	—	—
Share premium	631,722,000 EUR	—	—	—	—	—	—	—	711,874,000 EUR	—	—	—	—	—	—	—	—	—	—	—	—
Equity attributable to owners of parent	30,284,000 EUR	—	—	—	—	—	—	—	33,897,000 EUR	—	—	—	—	—	—	—	—	—	—	—	—
Equity	30,284,000 EUR	5,843,000 EUR	631,722,000 EUR	7,502,000 EUR	443,363,000 EUR	220,302,000 EUR	30,284,000 EUR	526,405,000 EUR	33,897,000 EUR	5,572,000 EUR	33,897,000 EUR	711,874,000 EUR	6,862,000 EUR	220,657,000 EUR	455,343,000 EUR	36,824,000 EUR	220,657,000 EUR	5,153,000 EUR	711,874,000 EUR	6,102,000 EUR	36,824,000 EUR
Equity and liabilities	114,277,000 EUR	—	—	—	—	—	—	—	142,480,000 EUR	—	—	—	—	—	—	—	—	—	—	—	—